Growth Metrics

Insulet (PODD) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 510.55%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 510.55%
Dec 31, 2025 53.48%
Sep 30, 2025 30.39%
Jun 30, 2025 98.04%
Mar 31, 2025 88.12%
Dec 31, 2024 98.19%
Sep 30, 2024 83.69%
Jun 30, 2024 68.02%
Mar 31, 2024 65.04%
Dec 31, 2023 38.54%
Sep 30, 2023 8.21%
Jun 30, 2023 18.56%
Mar 31, 2023 28.84%
Dec 31, 2022 2.63%
Sep 30, 2022 22.16%
Jun 30, 2022 22.10%
Mar 31, 2022 -60.15%
Dec 31, 2021 -41.58%
Sep 30, 2021 -53.65%
Jun 30, 2021 70.84%
Mar 31, 2021 -101.88%
Dec 31, 2020 -8.09%
Sep 30, 2020 23.83%
Jun 30, 2020 13.69%
Mar 31, 2020 45.17%
Dec 31, 2019 32.70%
Sep 30, 2019 126.48%
Jun 30, 2019 55.72%
Mar 31, 2019 37.82%
Dec 31, 2018 53.79%
Sep 30, 2018 21.93%
Jun 30, 2018 -114.05%
Mar 31, 2018 -6.94%
Dec 31, 2017 68.12%
Sep 30, 2017 69.01%
Jun 30, 2017 228.23%
Mar 31, 2017 -177.94%
Dec 31, 2016 97.51%
Sep 30, 2016 -10.18%
Jun 30, 2016 -5.57%
Mar 31, 2016 -106.18%
Dec 31, 2015 -49.25%
Sep 30, 2015 65.53%
Jun 30, 2015 27.46%
Mar 31, 2015 26.83%
Dec 31, 2014 37.52%
Sep 30, 2014 98.05%
Jun 30, 2014 27.16%
Mar 31, 2014 49.43%
Dec 31, 2013 22.99%
Sep 30, 2013 31.75%